24,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
12 °P sammeln
  • Broschiertes Buch

This book contains the results and additional details about a Cost-Effectiveness Analysis of IEV versus ESHAP for Treatment of the Patients with Relapsed/Refractory Hodgkin and Non-Hodgkin's Lymphoma in Iran. This book was provided by Mr. Mostafa Habibian, in partial fulfilment of the requirements for MSc in Health Economic. The present book was adopted from the proposal number 7044 approved by Vice Chancellor for Research Affairs of Shiraz University of Medical Sciences.

Produktbeschreibung
This book contains the results and additional details about a Cost-Effectiveness Analysis of IEV versus ESHAP for Treatment of the Patients with Relapsed/Refractory Hodgkin and Non-Hodgkin's Lymphoma in Iran. This book was provided by Mr. Mostafa Habibian, in partial fulfilment of the requirements for MSc in Health Economic. The present book was adopted from the proposal number 7044 approved by Vice Chancellor for Research Affairs of Shiraz University of Medical Sciences.
Autorenporträt
Mostafa Habibian, MSc in Gesundheitsökonomie, Shiraz University of Medical Sciences, 2012-2014 und BSc in Management von Gesundheitsdiensten, 2007-2011. Chefarzt für Kostenüberwachung in der Medizin und Forschungsstipendiat für Gesundheitsökonomie an der Iran University of Medical Sciences.